PL398536A1 - Pochodne pirazolu i kompozycje farmaceutyczne zawierające je oraz ich zastosowanie do leczenia HIV - Google Patents

Pochodne pirazolu i kompozycje farmaceutyczne zawierające je oraz ich zastosowanie do leczenia HIV

Info

Publication number: PL398536A1
Authority: PL; Poland
Prior art keywords: compositions containing; pyrazole derivatives; application; pharmaceutical compositions; compounds
Prior art date: 2001-04-10

Application number

PL398536A

Other languages

English (en)

Other versions

PL217629B1 (pl

Inventor

Lyn Howard Jones

Charles Eric Mowbray

David Anthony Price

Matthew Duncan Selby

Paul Anthony Stupple

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-10

Filing date

2002-04-04

Publication date

2012-06-04

2001-04-10 Priority claimed from GB0108999A external-priority patent/GB0108999D0/en

2001-11-15 Priority claimed from GB0127426A external-priority patent/GB0127426D0/en

2002-04-04 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2012-06-04 Publication of PL398536A1 publication Critical patent/PL398536A1/pl

2014-08-29 Publication of PL217629B1 publication Critical patent/PL217629B1/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

PL398536A 2001-04-10 2002-04-04 Pochodne pirazolu i kompozycje farmaceutyczne zawierające je oraz ich zastosowanie PL217629B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0108999A GB0108999D0 (en)	2001-04-10	2001-04-10	Pyrazole derivatives
GB0127426A GB0127426D0 (en)	2001-11-15	2001-11-15	Pyrazole derivatives

Publications (2)

Publication Number	Publication Date
PL398536A1 true PL398536A1 (pl)	2012-06-04
PL217629B1 PL217629B1 (pl)	2014-08-29

Family

ID=26245955

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PL396946A PL217224B1 (pl)	2001-04-10	2002-04-04	Kompozycja farmaceutyczna oraz jej zastosowanie
PL365026A PL216985B1 (pl)	2001-04-10	2002-04-04	Pochodne pirazolu, kompozycja farmaceutyczna zawierająca je oraz ich zastosowania
PL398536A PL217629B1 (pl)	2001-04-10	2002-04-04	Pochodne pirazolu i kompozycje farmaceutyczne zawierające je oraz ich zastosowanie

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
PL396946A PL217224B1 (pl)	2001-04-10	2002-04-04	Kompozycja farmaceutyczna oraz jej zastosowanie
PL365026A PL216985B1 (pl)	2001-04-10	2002-04-04	Pochodne pirazolu, kompozycja farmaceutyczna zawierająca je oraz ich zastosowania

Country Status (42)

Country	Link
US (4)	US7109228B2 (pl)
EP (2)	EP1762567B1 (pl)
JP (1)	JP3806090B2 (pl)
KR (1)	KR100569324B1 (pl)
CN (1)	CN100408564C (pl)
AR (2)	AR037319A1 (pl)
AT (2)	ATE556059T1 (pl)
AU (1)	AU2002242926B2 (pl)
BG (1)	BG66349B1 (pl)
BR (1)	BRPI0208811B8 (pl)
CA (1)	CA2443449C (pl)
CR (1)	CR7069A (pl)
CY (2)	CY1107626T1 (pl)
CZ (1)	CZ305099B6 (pl)
DE (1)	DE60219292T2 (pl)
DK (2)	DK1377556T3 (pl)
DO (1)	DOP2002000378A (pl)
EA (1)	EA007184B1 (pl)
EE (1)	EE05400B1 (pl)
ES (2)	ES2385659T3 (pl)
GE (1)	GEP20053619B (pl)
HR (1)	HRP20030783B1 (pl)
HU (1)	HU229025B1 (pl)
IL (2)	IL157875A0 (pl)
IS (1)	IS2734B (pl)
MA (1)	MA27009A1 (pl)
ME (1)	ME00558A (pl)
MX (1)	MXPA03009380A (pl)
MY (1)	MY146669A (pl)
NO (1)	NO326518B1 (pl)
NZ (1)	NZ529403A (pl)
OA (1)	OA12501A (pl)
PA (1)	PA8543601A1 (pl)
PE (1)	PE20021056A1 (pl)
PL (3)	PL217224B1 (pl)
PT (2)	PT1762567E (pl)
RS (1)	RS51166B (pl)
SI (2)	SI1762567T1 (pl)
SK (1)	SK287858B6 (pl)
TW (1)	TWI333488B (pl)
UY (1)	UY27248A1 (pl)
WO (1)	WO2002085860A1 (pl)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002242926B2 (en) *	2001-04-10	2007-10-11	Pfizer Inc.	Pyrazole derivatives for treating HIV
JP2005516964A (ja) *	2001-12-28	2005-06-09	バイエル・フアーマシユーチカルズ・コーポレーシヨン	５−ｈｔ２ｃレセプターと関連する疾患における使用のための１ｈ−ピラゾリル誘導体化合物
JP4228587B2 (ja) *	2002-05-22	2009-02-25	昭和電工株式会社	アミノメチル基含有ベンズアミド化合物の製造方法
US20040132793A1 (en) *	2002-09-16	2004-07-08	Pfizer Inc.	Pyrazole derivatives
GB0221477D0 (en) *	2002-09-16	2002-10-23	Pfizer Ltd	Chemical compounds
GB0223234D0 (en) *	2002-10-07	2002-11-13	Pfizer Ltd	Chemical compounds
US6933312B2 (en)	2002-10-07	2005-08-23	Agouron Pharmaceuticals, Inc.	Pyrazole derivatives
GB0223232D0 (en) *	2002-10-07	2002-11-13	Pfizer Ltd	Chemical compounds
TW200423930A (en) *	2003-02-18	2004-11-16	Hoffmann La Roche	Non-nucleoside reverse transcriptase inhibitors
CA2518823A1 (en)	2003-03-24	2004-10-07	F.Hoffmann-La Roche Ag	Benzyl-pyridazinons as reverse transcriptase inhibitors
JP2006526017A (ja) *	2003-05-14	2006-11-16	サイトキネティクス・インコーポレーテッド	化合物、組成物および方法
US7220772B2 (en)	2003-09-05	2007-05-22	Pfizer, Inc.	Pyrazole derivatives
US7102001B2 (en) *	2003-12-12	2006-09-05	Bristol-Myers Squibb Company	Process for preparing pyrrolotriazine
JP3997255B2 (ja)	2004-02-13	2007-10-24	ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー	アンドロゲンレセプターモジュレーター
BRPI0509759A (pt)	2004-04-13	2007-10-16	Warner Lambert Co	moduladores de androgênio
CA2562672C (en)	2004-04-22	2009-09-29	Warner-Lambert Company Llc	4-cyano-phenoxy derivatives as androgen modulators
AR048650A1 (es) *	2004-05-04	2006-05-10	Tibotec Pharm Ltd	Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
MXPA06015169A (es)	2004-07-08	2007-08-21	Warner Lambert Co	Moduladores de androgenos.
EP1874732A1 (en) *	2005-04-20	2008-01-09	Pfizer Limited	Pyrazole derivatives as progesterone receptor antagonists
TW200724139A (en)	2005-05-05	2007-07-01	Warner Lambert Co	Androgen modulators
AR057455A1 (es) *	2005-07-22	2007-12-05	Merck & Co Inc	Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
UA90763C2 (ru)	2005-11-08	2010-05-25	Пфайзер Лимитед	Производные пиразола, способ их получения, фармацевтический состав на их основе и их применение
BRPI0710487A2 (pt) *	2006-04-12	2012-06-05	Merck & Co Inc	composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitácel do mesmo e, método para tratar ou controlar a epilepsia e a dor e para o tratamento ou prevenção de um distúrbio do sono em um paciente.
PL2057125T3 (pl)	2006-08-16	2011-09-30	Hoffmann La Roche	Nienukleozydowe inhibitory odwrotnej transkryptazy
US20080096950A1 (en) *	2006-10-19	2008-04-24	Karl Richard Gibson	Compounds Useful In Therapy
US9280685B2 (en) *	2006-12-08	2016-03-08	Johnnie R. Jackson	System and method for portable medical records
WO2008135824A1 (en) *	2007-05-02	2008-11-13	Pfizer Limited	Oxyalkylpyrazole compounds useful in therapy
BRPI0813404A2 (pt)	2007-06-22	2014-12-30	Hoffmann La Roche	Derivados de uréia e carbamato como inibidores de transcriptase reversa de não-nucleosídeo
BRPI0818244A2 (pt)	2007-10-24	2015-06-16	Merck Sharp & Dohme	Composto, composição farmacêutica, uso de um composto, e, método para tratamento de um distúrbio ou doença
WO2009054983A1 (en) *	2007-10-24	2009-04-30	Merck & Co., Inc.	Heterocycle amide t-type calcium channel antagonists
RU2495878C2 (ru)	2007-12-21	2013-10-20	Ф.Хоффманн-Ля Рош Аг	Гетероциклические антивирусные соединения
NZ627827A (en)	2010-01-27	2016-02-26	Viiv Healthcare Co	Antiviral combinations involving (3s, 11ar)-n-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
CA2796269A1 (en) *	2010-04-13	2011-10-20	Sentreheart, Inc.	Methods and devices for accessing and delivering devices to a heart
US20140031250A1 (en)	2010-10-07	2014-01-30	David Tsai Ting	Biomarkers of Cancer
JP5886310B2 (ja) *	2010-12-06	2016-03-16	グラクソグループリミテッドＧｌａｘｏＧｒｏｕｐＬｉｍｉｔｅｄ	Ｌｐ−ＰＬＡ２により媒介される疾患または状態の処置における使用のためのピリミジノン化合物
WO2013050884A1 (en)	2011-10-07	2013-04-11	Phivco Uk Limited	Process for the preparation of lersivirine
WO2013057593A1 (en)	2011-10-07	2013-04-25	Phivco Uk Limited	Process for the preparation of lersivirine
WO2013050873A1 (en)	2011-10-07	2013-04-11	Phivco Uk Limited	Process for the preparation of lersivirine
EP2716632A1 (en) *	2012-10-05	2014-04-09	Laboratoire Biodim	Inhibitors of viral replication, their process of preparation and their therapeutical uses
WO2014074628A1 (en) *	2012-11-08	2014-05-15	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Compounds for treating hiv and methods for using the compounds
US10026064B2 (en)	2013-09-13	2018-07-17	Microsoft Technology Licensing, Llc	Automatically recommending updates based on stored lifecycle information
CA2937012A1 (en) *	2013-10-23	2015-04-30	Sumitomo Dainippon Pharma Co., Ltd.	Fused pyrazole derivative
US20170037014A1 (en) *	2014-05-06	2017-02-09	E. I. Du Pont De Nemours And Company	Fungicidal pyrazoles
WO2015200697A1 (en)	2014-06-25	2015-12-30	The General Hospital Corporation	Targeting human satellite ii (hsatii)
WO2016066664A1 (en) *	2014-10-31	2016-05-06	F. Hoffmann-La Roche Ag	New pyridinyloxy- and phenyloxy-pyrazolyl compounds
US9925190B2 (en)	2015-02-16	2018-03-27	University of Pittsburgh—of the Commonwealth System of Higher Education	Small molecules targeting HIV-1 Nef
JOP20180092A1 (ar) *	2017-10-13	2019-04-13	Gilead Sciences Inc	مثبطات hiv بروتياز
JP2021512956A (ja)	2018-02-06	2021-05-20	ザジェネラルホスピタルコーポレイション	腫瘍免疫応答のバイオマーカーとしてのリピートｒｎａ
KR102114389B1 (ko) *	2018-05-02	2020-05-25	이화여자대학교 산학협력단	신규 소듐채널 저해 화합물, 이의 제조방법, 및 이를 포함하는 소듐채널 관련 질환의 예방 또는 치료용 약학적 조성물
WO2020056564A1 (zh)	2018-09-17	2020-03-26	南通纺织丝绸产业技术研究院	基于金属氢化物/钯化合物体系制备1,3-二羰基化合物的方法
TW202028195A (zh) *	2018-10-18	2020-08-01	大陸商南京聖和藥業股份有限公司	作為TGF-βR1抑制劑的化合物及其應用
CN113527306B (zh) *	2020-04-17	2025-06-24	南京圣和药物研发有限公司	喹啉类TGF-β1抑制剂的晶型
CN113527304B (zh) *	2020-04-17	2025-08-12	南京圣和药物研发有限公司	喹啉类TGF-β1抑制剂的制备方法
EP4541790A1 (en)	2022-06-15	2025-04-23	Nissan Chemical Corporation	Pyrazole compound, production intermediate thereof, and pest control agent
WO2024204842A1 (ja)	2023-03-31	2024-10-03	日産化学株式会社	ピラゾール化合物及び有害生物防除剤

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3303200A (en) *	1963-11-05	1967-02-07	American Home Prod	Pyrazole-1-ethanol derivatives
US3963742A (en) *	1974-07-12	1976-06-15	American Cyanamid Company	1,2-Dialkyl-3,4,5-trisubstituted pyrazolium salts as herbicidal agents
US4009277A (en) *	1975-01-17	1977-02-22	American Cyanamid Company	1,2-Dialkyl-3,4,5-trisubstituted pyrazolium salts as fungicidal agents
US4041046A (en)	1975-06-06	1977-08-09	American Cyanamid Company	1,2-Dialkyl-3,4,5-trisubstituted pyrazole compounds
US4000301A (en)	1975-11-14	1976-12-28	American Cyanamid Company	Fungicidal use of 4-alkoxypyrazoles
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
JPH0565237A (ja)	1991-09-10	1993-03-19	Mitsubishi Heavy Ind Ltd	メタノールを媒体としたエネルギ供給方法
FR2682379B1 (fr)	1991-10-09	1994-02-11	Rhone Poulenc Agrochimie	Nouveaux phenylpyrazoles fongicides.
WO1994022830A1 (en)	1993-03-31	1994-10-13	Smithkline Beecham Corporation	Chemical compounds
FR2707295A1 (fr)	1993-06-07	1995-01-13	Rhone Poulenc Agrochimie	Fongicides pyrazoles substitués en position 3 par un hétérocycle.
DE69408950T2 (de)	1993-12-14	1998-10-15	Mitsubishi Chem Corp	N-Pyrazolylcarbamatderivate und Fungizide für Landwirtschaft und Gartenbau, die diese als aktive Bestandteile erhalten, Produktion und Zwischenprodukte
FR2722369B1 (fr)	1994-07-13	1998-07-10	Rhone Poulenc Agrochimie	Compositions fongicides a base de derives 3-phenyl-pyrazoles pour le traitement du materiel vegetal de multiplication, nouveaux derives 3-phenyl-pyrazoles et leurs applications fongicides
DK0786455T3 (da)	1994-09-26	2004-03-29	Shionogi & Co	Imidazolderivater
TW343232B (en) *	1994-10-13	1998-10-21	Chisso Corp	Difluorooxymethane derivative and liquid crystal composition
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
AU2001259691B2 (en) *	2000-05-12	2006-02-16	Genzyme Corporation	Modulators of TNF-alpha signaling
GB0016787D0 (en)	2000-07-07	2000-08-30	Pfizer Ltd	Compounds useful in therapy
AU2002242926B2 (en) *	2001-04-10	2007-10-11	Pfizer Inc.	Pyrazole derivatives for treating HIV

2002
- 2002-04-04 AU AU2002242926A patent/AU2002242926B2/en not_active Expired
- 2002-04-04 EP EP06126433A patent/EP1762567B1/en not_active Expired - Lifetime
- 2002-04-04 ES ES06126433T patent/ES2385659T3/es not_active Expired - Lifetime
- 2002-04-04 EE EEP200300497A patent/EE05400B1/xx unknown
- 2002-04-04 DE DE60219292T patent/DE60219292T2/de not_active Expired - Lifetime
- 2002-04-04 ME MEP-758/08A patent/ME00558A/xx unknown
- 2002-04-04 AT AT06126433T patent/ATE556059T1/de active
- 2002-04-04 ES ES02708600T patent/ES2283532T3/es not_active Expired - Lifetime
- 2002-04-04 GE GE5299A patent/GEP20053619B/en unknown
- 2002-04-04 PL PL396946A patent/PL217224B1/pl unknown
- 2002-04-04 MX MXPA03009380A patent/MXPA03009380A/es active IP Right Grant
- 2002-04-04 HR HR20030783A patent/HRP20030783B1/xx not_active IP Right Cessation
- 2002-04-04 RS YUP-775/03A patent/RS51166B/sr unknown
- 2002-04-04 EP EP02708600A patent/EP1377556B1/en not_active Expired - Lifetime
- 2002-04-04 PT PT06126433T patent/PT1762567E/pt unknown
- 2002-04-04 BR BRPI0208811-8 patent/BRPI0208811B8/pt not_active IP Right Cessation
- 2002-04-04 SI SI200230986T patent/SI1762567T1/sl unknown
- 2002-04-04 PL PL365026A patent/PL216985B1/pl unknown
- 2002-04-04 IL IL15787502A patent/IL157875A0/xx unknown
- 2002-04-04 EA EA200300943A patent/EA007184B1/ru not_active IP Right Cessation
- 2002-04-04 CZ CZ2003-2676A patent/CZ305099B6/cs not_active IP Right Cessation
- 2002-04-04 JP JP2002583387A patent/JP3806090B2/ja not_active Expired - Lifetime
- 2002-04-04 SK SK1244-2003A patent/SK287858B6/sk unknown
- 2002-04-04 HU HU0303735A patent/HU229025B1/hu unknown
- 2002-04-04 PT PT02708600T patent/PT1377556E/pt unknown
- 2002-04-04 DK DK02708600T patent/DK1377556T3/da active
- 2002-04-04 PL PL398536A patent/PL217629B1/pl unknown
- 2002-04-04 OA OA1200300258A patent/OA12501A/en unknown
- 2002-04-04 CN CNB028116259A patent/CN100408564C/zh not_active Expired - Lifetime
- 2002-04-04 CA CA002443449A patent/CA2443449C/en not_active Expired - Lifetime
- 2002-04-04 DK DK06126433.9T patent/DK1762567T3/da active
- 2002-04-04 WO PCT/IB2002/001234 patent/WO2002085860A1/en not_active Ceased
- 2002-04-04 SI SI200230529T patent/SI1377556T1/sl unknown
- 2002-04-04 AT AT02708600T patent/ATE358669T1/de active
- 2002-04-04 NZ NZ529403A patent/NZ529403A/en not_active IP Right Cessation
- 2002-04-04 KR KR1020037013352A patent/KR100569324B1/ko not_active Expired - Fee Related
- 2002-04-05 US US10/118,512 patent/US7109228B2/en not_active Expired - Lifetime
- 2002-04-08 MY MYPI20021264A patent/MY146669A/en unknown
- 2002-04-08 AR ARP020101281A patent/AR037319A1/es active IP Right Grant
- 2002-04-09 UY UY27248A patent/UY27248A1/es not_active IP Right Cessation
- 2002-04-09 TW TW091107115A patent/TWI333488B/zh not_active IP Right Cessation
- 2002-04-10 PE PE2002000297A patent/PE20021056A1/es active IP Right Grant
- 2002-04-10 PA PA20028543601A patent/PA8543601A1/es unknown
- 2002-04-10 DO DO2002000378A patent/DOP2002000378A/es unknown
2003
- 2003-09-04 IS IS6939A patent/IS2734B/is unknown
- 2003-09-09 CR CR7069A patent/CR7069A/es unknown
- 2003-09-11 IL IL157875A patent/IL157875A/en active IP Right Grant
- 2003-10-06 MA MA27336A patent/MA27009A1/fr unknown
- 2003-10-08 BG BG108244A patent/BG66349B1/bg unknown
- 2003-10-09 NO NO20034523A patent/NO326518B1/no not_active IP Right Cessation
2005
- 2005-06-20 US US11/157,340 patent/US7435728B2/en not_active Expired - Lifetime
2007
- 2007-05-10 CY CY20071100627T patent/CY1107626T1/el unknown
2008
- 2008-08-25 US US12/197,655 patent/US8063044B2/en not_active Expired - Fee Related
2010
- 2010-03-19 AR ARP100100890A patent/AR076259A2/es active IP Right Grant
2011
- 2011-10-07 US US13/269,278 patent/US20120029192A1/en not_active Abandoned
2012
- 2012-06-27 CY CY20121100571T patent/CY1113515T1/el unknown

Also Published As

Publication number	Publication date
NO20034523D0 (no)	2003-10-09
EP1762567A1 (en)	2007-03-14
GEP20053619B (en)	2005-09-26
CZ305099B6 (cs)	2015-05-06
US7435728B2 (en)	2008-10-14
CN100408564C (zh)	2008-08-06
EP1762567B1 (en)	2012-05-02
TWI333488B (en)	2010-11-21
DE60219292D1 (de)	2007-05-16
MXPA03009380A (es)	2004-04-21
OA12501A (en)	2006-05-26
PT1762567E (pt)	2012-07-16
IS6939A (is)	2003-09-04
HRP20030783A2 (en)	2005-08-31
BG66349B1 (bg)	2013-08-30
JP3806090B2 (ja)	2006-08-09
CA2443449C (en)	2008-11-04
SI1762567T1 (sl)	2012-08-31
NO326518B1 (no)	2008-12-22
IL157875A (en)	2010-05-17
US20090215712A1 (en)	2009-08-27
CR7069A (es)	2007-12-17
AR076259A2 (es)	2011-06-01
ES2385659T3 (es)	2012-07-27
EP1377556A1 (en)	2004-01-07
UY27248A1 (es)	2002-11-29
ATE556059T1 (de)	2012-05-15
US20060020012A1 (en)	2006-01-26
EE200300497A (et)	2004-02-16
ES2283532T3 (es)	2007-11-01
DOP2002000378A (es)	2002-10-15
KR20040007496A (ko)	2004-01-24
SI1377556T1 (sl)	2007-08-31
BG108244A (bg)	2005-04-30
AU2002242926B2 (en)	2007-10-11
DK1377556T3 (da)	2007-07-16
WO2002085860A1 (en)	2002-10-31
BR0208811A (pt)	2004-03-09
BRPI0208811B8 (pt)	2021-05-25
ME00558A (en)	2011-12-20
HU229025B1 (en)	2013-07-29
SK12442003A3 (sk)	2004-12-01
PL217224B1 (pl)	2014-06-30
HK1063781A1 (zh)	2005-01-14
YU77503A (sh)	2006-05-25
ATE358669T1 (de)	2007-04-15
PT1377556E (pt)	2007-06-06
US20030100554A1 (en)	2003-05-29
PL217629B1 (pl)	2014-08-29
MA27009A1 (fr)	2004-12-20
EA007184B1 (ru)	2006-08-25
DK1762567T3 (da)	2012-06-25
BRPI0208811B1 (pt)	2018-03-13
CY1113515T1 (el)	2016-06-22
IS2734B (is)	2011-04-15
US20120029192A1 (en)	2012-02-02
NO20034523L (no)	2003-12-09
DE60219292T2 (de)	2008-04-10
IL157875A0 (en)	2004-03-28
CZ20032676A3 (cs)	2004-11-10
JP2004531535A (ja)	2004-10-14
HUP0303735A2 (hu)	2004-03-01
PL216985B1 (pl)	2014-06-30
NZ529403A (en)	2005-06-24
RS51166B (sr)	2010-10-31
SK287858B6 (sk)	2012-01-04
AR037319A1 (es)	2004-11-03
EP1377556B1 (en)	2007-04-04
EE05400B1 (et)	2011-04-15
HRP20030783B1 (hr)	2011-11-30
US7109228B2 (en)	2006-09-19
KR100569324B1 (ko)	2006-04-07
PL396946A1 (pl)	2012-01-02
MY146669A (en)	2012-09-14
PE20021056A1 (es)	2002-12-03
CA2443449A1 (en)	2002-10-31
EA200300943A1 (ru)	2004-08-26
PA8543601A1 (es)	2002-10-31
PL365026A1 (pl)	2004-12-27
US8063044B2 (en)	2011-11-22
HUP0303735A3 (en)	2004-07-28
CN1514828A (zh)	2004-07-21
CY1107626T1 (el)	2013-04-18

Publication	Publication Date	Title
PL398536A1 (pl)	2012-06-04	Pochodne pirazolu i kompozycje farmaceutyczne zawierające je oraz ich zastosowanie do leczenia HIV
NO20052739L (no)	2005-08-19	CCR5-antagonister som medikamenter
CY1111693T1 (el)	2015-10-07	Αντιιικοι παραγοντες
HUP0101999A2 (hu)	2001-11-28	4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
PT1263730E (pt)	2008-02-11	Derivados amina para o tratamento de apoptose
EA200600225A1 (ru)	2006-08-25	Производные пиперазина для лечения вич инфекций
NO20035583D0 (no)	2003-12-15	Imidazo` 1,2-A pyridinderivater for profylakse og behandling av herpes virale infeksjoner
CA2075173A1 (en)	1993-02-03	Compounds and methods for inhibition of hiv and related viruses
NO20070258L (no)	2007-01-15	Benzyltriazolonforbindelser som ikke-nukleoside revers transkriptase inhibitorer
NO20040881L (no)	2004-04-19	Orale antidiabetes midler.
DE60318874D1 (en)	2008-03-13	Pyrazolderivate
MXPA02012409A (es)	2003-04-25	Derivados de pirrol para tratamiento del sida.
BR0314759A (pt)	2005-07-26	Derivados de pirazol
NO983444D0 (no)	1998-07-24	Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
GB0223234D0 (en)	2002-11-13	Chemical compounds
HUP0203161A2 (hu)	2002-12-28	Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AP1846A (en)	2008-05-09	Pyrazole Derivatives.
EA200500287A1 (ru)	2005-10-27	Производные 4-(3, 5-дицианофенокси)пиразола для применения в качестве модуляторов обратной транскриптазы в лечении, в числе прочего, вич-инфекции
HUP0402149A2 (hu)	2005-02-28	Vízoldható fenil-piridazin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
DK1451184T3 (da)	2008-10-27	Dimere forbindelser og deres anvendelse som antivirale midler